Comments on prospective study of metabolic syndrome as a mortality marker in chronic coronary heart disease patients

We have read the article by Mayer O Jr et al. that was published in European Journal of Internal Medicine [1]. The authors tried to assess the effect of metabolic syndrome (MetS) as assessed by different definitions on the cardiovascular mortality in patients with coronary heart disease (CHD) [1].